1
|
Abstract
Summary Background. Kounis syndrome (KS) is defined as a rare cause of an acute coronary syndrome associated with systemic allergic reactions. To establish the prevalence of KS among the patients with diagnosis of anaphylaxis, we described clinical features, cardiological and allergological outcomes of patients evaluated in our allergy outpatient clinic. Methods. A retrospective study was carried out in the Allergy Unit of Novara hospital, from January 2008 to March 2020. Skin tests and in vitro tests were performed with suspected etiological agents. Results. We found 9 adults with KS (2%) out of 444 subjects who had experienced anaphylactic reactions (4/9 to Hymenoptera stings, 5/9 to drugs). Conclusions. The present study highlights the importance of suspicion of KS that appears not so uncommon in patients with anaphylaxis. KS seems to be a rare disease because unrecognized in diagnosis of anaphylaxis.
Collapse
Affiliation(s)
- G Zisa
- Allergy Unit, Department of Internal Medicine, Hospital Maggiore della Carità, Novara, Italy
| | - A Panero
- Department of Medicine, Hospital of Biella, Biella, Italy
| | - A Re
- Department of Medicine, Hospital Maggiore della Carità, Novara, Italy
| | - M G Mennuni
- Division of Cardiology, Hospital Maggiore della Carità, Novara, Italy
| | - G Patti
- Division of Cardiology, Hospital Maggiore della Carità, Novara, Italy
- Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
| | - M Pirisi
- Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy
- Division of Internal Medicine, Hospital Maggiore della Carità, Novara, Italy
| |
Collapse
|
2
|
Renda G, Mennuni MG, Pizzoferrato G, Esposto D, Alberani A, De Vecchi S, Degiovanni A, Giubertoni A, Spinoni EG, Grisafi L, Sagazio E, Ucciferri C, Falasca K, Vecchiet J, Gallina S, Patti G. Predictive Value of Echocardiographic Pulmonary to Left Atrial Ratio for In-Hospital Death in Patients with COVID-19. Diagnostics (Basel) 2023; 13:diagnostics13020224. [PMID: 36673034 PMCID: PMC9857775 DOI: 10.3390/diagnostics13020224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2022] [Revised: 12/07/2022] [Accepted: 12/29/2022] [Indexed: 01/11/2023] Open
Abstract
Background: Echocardiographic Pulmonary to Left Atrial Ratio (ePLAR) represents an accurate and sensitive non-invasive tool to estimate the trans-pulmonary gradient. The prognostic value of ePLAR in hospitalized patients with COVID-19 remains unknown. We aimed to investigate the predictive value of ePLAR on in-hospital mortality in patients with COVID-19. Methods: One hundred consecutive patients admitted to two Italian institutions for COVID-19 undergoing early (<24 h) echocardiographic examination were included; ePLAR was determined from the maximum tricuspid regurgitation continuous wave Doppler velocity (m/s) divided by the transmitral E-wave: septal mitral annular Doppler Tissue Imaging e′-wave ratio (TRVmax/E:e′). The primary outcome measure was in-hospital death. Results: patients who died during hospitalization had at baseline a higher prevalence of tricuspid regurgitation, higher ePLAR, right-side pressures, lower Tricuspid Annular Plane Systolic Excursion (TAPSE)/ systolic Pulmonary Artery Pressure (sPAP) ratio and reduced inferior vena cava collapse than survivors. Patients with ePLAR > 0.28 m/s at baseline showed non-significant but markedly increased in-hospital mortality compared to those having ePLAR ≤ 0.28 m/s (27% vs. 10.8%, p = 0.055). Multivariate Cox regression showed that an ePLAR > 0.28 m/s was independently associated with an increased risk of death (HR 5.07, 95% CI 1.04−24.50, p = 0.043), particularly when associated with increased sPAP (p for interaction = 0.043). Conclusions: A high ePLAR value at baseline predicts in-hospital death in patients with COVID-19, especially in those with elevated pulmonary arterial pressure. These results support an early ePLAR assessment in patients admitted for COVID-19 to identify those at higher risk and potentially guide strategies of diagnosis and care.
Collapse
Affiliation(s)
- Giulia Renda
- Institute of Cardiology, Department of Neuroscience, Imaging and Clinical Sciences, G. d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy
- SS. Annunziata Hospital of Chieti, 66100 Chieti, Italy
| | - Marco G. Mennuni
- Maggiore della Carità Hospital, 28100 Novara, Italy
- Correspondence: ; Tel.: +39-032-1373-3648
| | - Giovanni Pizzoferrato
- Institute of Cardiology, Department of Neuroscience, Imaging and Clinical Sciences, G. d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy
- SS. Annunziata Hospital of Chieti, 66100 Chieti, Italy
| | - Daniele Esposto
- Institute of Cardiology, Department of Neuroscience, Imaging and Clinical Sciences, G. d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy
- SS. Annunziata Hospital of Chieti, 66100 Chieti, Italy
| | - Angela Alberani
- Institute of Cardiology, Department of Neuroscience, Imaging and Clinical Sciences, G. d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy
- SS. Annunziata Hospital of Chieti, 66100 Chieti, Italy
| | | | | | | | - Enrico Guido Spinoni
- Translational Medicine Department, University of Eastern Piedmont, 28100 Novara, Italy
| | - Leonardo Grisafi
- Translational Medicine Department, University of Eastern Piedmont, 28100 Novara, Italy
| | - Emanuele Sagazio
- Translational Medicine Department, University of Eastern Piedmont, 28100 Novara, Italy
| | - Claudio Ucciferri
- SS. Annunziata Hospital of Chieti, 66100 Chieti, Italy
- Clinic of Infectious Diseases, Department of Medicine and Science of Aging, G. d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy
| | - Katia Falasca
- SS. Annunziata Hospital of Chieti, 66100 Chieti, Italy
- Clinic of Infectious Diseases, Department of Medicine and Science of Aging, G. d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy
| | - Jacopo Vecchiet
- SS. Annunziata Hospital of Chieti, 66100 Chieti, Italy
- Clinic of Infectious Diseases, Department of Medicine and Science of Aging, G. d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy
| | - Sabina Gallina
- Institute of Cardiology, Department of Neuroscience, Imaging and Clinical Sciences, G. d’Annunzio University of Chieti-Pescara, 66100 Chieti, Italy
| | - Giuseppe Patti
- Maggiore della Carità Hospital, 28100 Novara, Italy
- Translational Medicine Department, University of Eastern Piedmont, 28100 Novara, Italy
| |
Collapse
|
3
|
Mennuni MG, Solli M, Galiffa V, Patti G. Unmasking of a significant left main stenosis in a patient with high left ventricular pressures. Catheter Cardiovasc Interv 2022; 100:216-218. [PMID: 35708098 PMCID: PMC9543501 DOI: 10.1002/ccd.30297] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/15/2022] [Revised: 05/18/2022] [Accepted: 05/29/2022] [Indexed: 01/09/2023]
Abstract
As identification of left main (LM) stenoses has prognostic and therapeutic relevance, a precise anatomic and/or functional characterization of angiographically intermediate LM stenoses, by using intravascular ultrasound (IVUS) and fractional flow reserve (FFR) respectively, is crucial (1). However, increased left ventricular (LV) pressures might affect FFR measurements (2). Here we describe the case of a patient with chronic coronary syndrome and severe LV dysfunction in whom coronary angiography revealed an intermediate LM stenosis and catheterization identified an increased LV end‐diastolic pressure. FFR measurement showed disproportionally higher FFR values compared with the minimal luminal area assessed by IVUS. When cardiac output was artificially augmented by using Impella for assisting percutaneous coronary intervention, the value of FFR measurement turned out proportional to what expected for the degree of anatomical stenosis. This discrepancy between anatomic and functional measurement may be a sign of coronary autoregulation dysfunction and therefore could help to identify high‐risk patients in whom the use of a mechanical support device is more beneficial during percutaneous revascularization.
Collapse
Affiliation(s)
- Marco G Mennuni
- Division of Cardiology, Interventional Cardiology, Maggiore della Carità Hospital, Novara, Italy
| | - Martina Solli
- Division of Cardiology, Interventional Cardiology, Maggiore della Carità Hospital, Novara, Italy
| | - Vincenzo Galiffa
- Division of Cardiology, Interventional Cardiology, Maggiore della Carità Hospital, Novara, Italy
| | - Giuseppe Patti
- Division of Cardiology, Interventional Cardiology, Maggiore della Carità Hospital, Novara, Italy.,Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy
| |
Collapse
|
4
|
Mennuni MG, Sagazio E, Patti G. In‐Stent Restenosis in the New Generation DES Era. Interv Cardiol 2022. [DOI: 10.1002/9781119697367.ch21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
|
5
|
Lafont A, Mennuni MG. Older women in emergency care: a particular risk of marginalisation. The Lancet Healthy Longevity 2021; 2:e236-e237. [DOI: 10.1016/s2666-7568(21)00094-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2021] [Accepted: 04/21/2021] [Indexed: 10/21/2022] Open
|
6
|
Fajadet J, Mennuni MG, Carrié D, Barragan P, Coste P, Vert M, Lafont A. First-in-Man trial of a drug-free bioresorbable stent designed to minimize the duration of coronary artery scaffolding. J Biomater Sci Polym Ed 2021; 32:1251-1266. [PMID: 33792525 DOI: 10.1080/09205063.2021.1910919] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
For the last two decades, various degradable stents have been proposed to treat coronary artery diseases and replace metallic stents to avoid residual foreign material after healing. To date, the right balance between suitable scaffolding and loss of radial strength soon after endothelium restoration is still an unmet need. The present article reports on the First-in-Man trial of a drug-free bioresorbable stent based on a lactic acid stereocopolymer composed of 98% l-lactyl units selected to release stress shielding earlier than in the case of homopoly(l-lactic acid). Thirty patients with single de novo coronary lesions were included in the trial. The fate of scaffolds was monitored by clinical and imaging follow-ups to assess rate of adverse events, acute recoil, late luminal loss, and late lumen recovery. There was no death, no myocardial infarction, and no stent thrombosis observed over the 36 months trial. Dismantling occurred about 3 months after implantation. Bioresorption was almost completed at 2 years. The late lumen loss observed at the end of the first year was partly compensated one year later by enlarging remodeling. At one year, a neointimal hyperplasia slightly greater than for drug-eluting metallic and bioresorbable stents was shown using optical coherence tomography. The excess of hyperplasia was discussed relative to struts thickness, absence of anti-proliferative drug, and release of degradation by-products.
Collapse
Affiliation(s)
| | - Marco G Mennuni
- Hôpital Européen Georges Pompidou, Centre Hospitalier Universitaire Paris-Descartes, APHP, Paris, France
| | - Didier Carrié
- Centre Hospitalier Universitaire Rangueil, Toulouse, France
| | | | - Pierre Coste
- Centre Hospitalier Universitaire Bordeaux Pessac, Bordeaux University, Bordeaux, France
| | - Michel Vert
- UMR CNRS 5247, Faculty of Pharmacy, University-ENSCM, Montpellier, France
| | - Antoine Lafont
- Hôpital Européen Georges Pompidou, Centre Hospitalier Universitaire Paris-Descartes, APHP, Paris, France
| |
Collapse
|
7
|
Mennuni MG, Renda G, Grisafi L, Rognoni A, Colombo C, Lio V, Foglietta M, Petrilli I, Pirisi M, Spinoni E, Azzolina D, Hayden E, Aimaretti G, Avanzi GC, Bellan M, Cantaluppi V, Capponi A, Castello LM, D'Ardes D, Corte FD, Gallina S, Krengli M, Malerba M, Pierdomenico SD, Savoia P, Zeppegno P, Sainaghi PP, Cipollone F, Patti G. Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19. J Thromb Thrombolysis 2021; 52:782-790. [PMID: 33649979 PMCID: PMC7919624 DOI: 10.1007/s11239-021-02401-x] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 02/11/2021] [Indexed: 12/19/2022]
Abstract
A pro-thrombotic milieu and a higher risk of thrombotic events were observed in patients with CoronaVirus disease-19 (COVID-19). Accordingly, recent data suggested a beneficial role of low molecular weight heparin (LMWH), but the optimal dosage of this treatment is unknown. We evaluated the association between prophylactic vs. intermediate-to-fully anticoagulant doses of enoxaparin and in-hospital adverse events in patients with COVID-19. We retrospectively included 436 consecutive patients admitted in three Italian hospitals. Outcome according to the use of prophylactic (4000 IU) vs. higher (> 4000 IU) daily dosage of enoxaparin was evaluated. The primary end-point was in-hospital death. Secondary outcome measures were in-hospital cardiovascular death, venous thromboembolism, new-onset acute respiratory distress syndrome (ARDS) and mechanical ventilation. A total of 287 patients (65.8%) were treated with the prophylactic enoxaparin regimen and 149 (34.2%) with a higher dosing regimen. The use of prophylactic enoxaparin dose was associated with a similar incidence of all-cause mortality (25.4% vs. 26.9% with the higher dose; OR at multivariable analysis, including the propensity score: 0.847, 95% CI 0.400–0.1.792; p = 0.664). In the prophylactic dose group, a significantly lower incidence of cardiovascular death (OR 0.165), venous thromboembolism (OR 0.067), new-onset ARDS (OR 0.454) and mechanical intubation (OR 0.150) was observed. In patients hospitalized for COVID-19, the use of a prophylactic dosage of enoxaparin appears to be associated with similar in-hospital overall mortality compared to higher doses. These findings require confirmation in a randomized, controlled study.
Collapse
Affiliation(s)
- Marco G Mennuni
- Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy
| | - Giulia Renda
- G. d'Annunzio University, Chieti-Pescara, Italy.,Ospedale Santissima Annunziata of Chieti, Chieti, Italy
| | - Leonardo Grisafi
- Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.,Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, UPO, Azienda Ospedaliero-Universitaria Maggiore della Carità, Via Solaroli 17, 28100, Novara, Italy
| | - Andrea Rognoni
- Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy
| | - Crizia Colombo
- Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.,Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, UPO, Azienda Ospedaliero-Universitaria Maggiore della Carità, Via Solaroli 17, 28100, Novara, Italy
| | - Veronica Lio
- Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.,Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, UPO, Azienda Ospedaliero-Universitaria Maggiore della Carità, Via Solaroli 17, 28100, Novara, Italy
| | - Melissa Foglietta
- G. d'Annunzio University, Chieti-Pescara, Italy.,Ospedale Santissima Annunziata of Chieti, Chieti, Italy
| | - Ivan Petrilli
- G. d'Annunzio University, Chieti-Pescara, Italy.,Ospedale Santissima Annunziata of Chieti, Chieti, Italy
| | - Mario Pirisi
- Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.,Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, UPO, Azienda Ospedaliero-Universitaria Maggiore della Carità, Via Solaroli 17, 28100, Novara, Italy
| | - Enrico Spinoni
- Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.,Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, UPO, Azienda Ospedaliero-Universitaria Maggiore della Carità, Via Solaroli 17, 28100, Novara, Italy
| | - Danila Azzolina
- Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, UPO, Azienda Ospedaliero-Universitaria Maggiore della Carità, Via Solaroli 17, 28100, Novara, Italy
| | - Eyal Hayden
- Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.,Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, UPO, Azienda Ospedaliero-Universitaria Maggiore della Carità, Via Solaroli 17, 28100, Novara, Italy
| | - Gianluca Aimaretti
- Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.,Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, UPO, Azienda Ospedaliero-Universitaria Maggiore della Carità, Via Solaroli 17, 28100, Novara, Italy
| | - Gian Carlo Avanzi
- Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.,Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, UPO, Azienda Ospedaliero-Universitaria Maggiore della Carità, Via Solaroli 17, 28100, Novara, Italy
| | - Mattia Bellan
- Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.,Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, UPO, Azienda Ospedaliero-Universitaria Maggiore della Carità, Via Solaroli 17, 28100, Novara, Italy
| | - Vincenzo Cantaluppi
- Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.,Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, UPO, Azienda Ospedaliero-Universitaria Maggiore della Carità, Via Solaroli 17, 28100, Novara, Italy
| | - Andrea Capponi
- Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy
| | - Luigi M Castello
- Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.,Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, UPO, Azienda Ospedaliero-Universitaria Maggiore della Carità, Via Solaroli 17, 28100, Novara, Italy
| | - Damiano D'Ardes
- G. d'Annunzio University, Chieti-Pescara, Italy.,Ospedale Santissima Annunziata of Chieti, Chieti, Italy
| | - Francesco Della Corte
- Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.,Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, UPO, Azienda Ospedaliero-Universitaria Maggiore della Carità, Via Solaroli 17, 28100, Novara, Italy
| | - Sabina Gallina
- G. d'Annunzio University, Chieti-Pescara, Italy.,Ospedale Santissima Annunziata of Chieti, Chieti, Italy
| | - Marco Krengli
- Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.,Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, UPO, Azienda Ospedaliero-Universitaria Maggiore della Carità, Via Solaroli 17, 28100, Novara, Italy
| | - Mario Malerba
- Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, UPO, Azienda Ospedaliero-Universitaria Maggiore della Carità, Via Solaroli 17, 28100, Novara, Italy.,Sant'Andrea Hospital, Vercelli, Italy
| | - Sante D Pierdomenico
- G. d'Annunzio University, Chieti-Pescara, Italy.,Ospedale Santissima Annunziata of Chieti, Chieti, Italy
| | - Paola Savoia
- Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.,Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, UPO, Azienda Ospedaliero-Universitaria Maggiore della Carità, Via Solaroli 17, 28100, Novara, Italy
| | - Patrizia Zeppegno
- Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.,Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, UPO, Azienda Ospedaliero-Universitaria Maggiore della Carità, Via Solaroli 17, 28100, Novara, Italy
| | - Pier P Sainaghi
- Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.,Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, UPO, Azienda Ospedaliero-Universitaria Maggiore della Carità, Via Solaroli 17, 28100, Novara, Italy
| | - Francesco Cipollone
- G. d'Annunzio University, Chieti-Pescara, Italy.,Ospedale Santissima Annunziata of Chieti, Chieti, Italy
| | - Giuseppe Patti
- Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy. .,Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, UPO, Azienda Ospedaliero-Universitaria Maggiore della Carità, Via Solaroli 17, 28100, Novara, Italy.
| | | |
Collapse
|
8
|
Pagnotta PA, Chiarito M, Pllaha E, Mantovani R, Mennuni MG, Rossi ML, Reimers B. [Two-step strategy for the treatment of complex coronary artery disease and aortic stenosis in a patient with severely impaired left ventricular function]. G Ital Cardiol (Rome) 2018; 19:191-193. [PMID: 29873647 DOI: 10.1714/2883.29078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Coronary artery disease and aortic stenosis frequently coexist. The pathophysiology of both conditions is similar where atherosclerosis is the hallmark feature. Risk factors for aortic stenosis are also similar for coronary artery disease. The standard therapy in the past decades has been coronary artery bypass grafting and aortic valve replacement; however, with the introduction of transcatheter aortic valve implantation their management is probably going to shift towards a percutaneous strategy.
Collapse
Affiliation(s)
- Paolo A Pagnotta
- Dipartimento Cardiovascolare, Humanitas Research Hospital, Rozzano (MI)
| | - Mauro Chiarito
- Dipartimento Cardiovascolare, Humanitas Research Hospital, Rozzano (MI)
| | - Elton Pllaha
- Dipartimento Cardiovascolare, Humanitas Research Hospital, Rozzano (MI)
| | | | - Marco G Mennuni
- Dipartimento Cardiovascolare, Humanitas Research Hospital, Rozzano (MI)
| | - Marco L Rossi
- Dipartimento Cardiovascolare, Humanitas Research Hospital, Rozzano (MI)
| | - Bernhard Reimers
- Dipartimento Cardiovascolare, Humanitas Research Hospital, Rozzano (MI)
| |
Collapse
|
9
|
Affiliation(s)
- Antoine Lafont
- From the APHP, Hôpital Européen Georges Pompidou, Paris, France (A.L.); Centre Hospitalier Universitaire Paris-Descartes, France (A.L.); INSERMU970, Paris, France (A.L.); and Cardiology Department, Ospedale Universitario Maggiore della Carità, Novara, Italy (M.G.M.)
| | - Marco G. Mennuni
- From the APHP, Hôpital Européen Georges Pompidou, Paris, France (A.L.); Centre Hospitalier Universitaire Paris-Descartes, France (A.L.); INSERMU970, Paris, France (A.L.); and Cardiology Department, Ospedale Universitario Maggiore della Carità, Novara, Italy (M.G.M.)
| |
Collapse
|
10
|
Theodoropoulos K, Mennuni MG, Sartori S, Meelu OA, Yu J, Baber U, Stefanini GG, Mastoris I, Moreno P, Dangas GD, Mehran R, Sharma SK, Kini AS. Quantitative angiographic characterisation of coronary artery disease in patients with human immunodeficiency virus (HIV) infection undergoing percutaneous coronary intervention. EUROINTERVENTION 2017; 12:1757-1765. [PMID: 27840323 DOI: 10.4244/eij-d-15-00409] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
AIMS Patients with human immunodeficiency virus (HIV) infection have an increased risk of acute myocardial infarction (MI), and 6.5-15% of mortality in this population is attributable to cardiovascular disease. However, the angiographic pattern of coronary artery disease (CAD) in patients with HIV undergoing percutaneous coronary intervention (PCI) remains unknown. We sought to assess and describe the angiographic features and burden of CAD in patients with HIV as compared to those without HIV infection. METHODS AND RESULTS This is a retrospective, single-centre study comparing 93 patients with HIV infection who underwent PCI between 2003 and 2011 with 93 control patients without HIV infection matched for age (±3 years), gender, diabetes, and year of PCI (±2 years). Quantitative coronary angiography (QCA) was performed for all treated lesions at baseline and following PCI in both groups. One-year clinical outcomes post PCI were also analysed and compared. The mean age for both study populations was 57 years; patients with HIV were more likely to present with ST-segment elevation myocardial infarction (STEMI). Patients had a similar extent of CAD as measured by the presence of multivessel disease as well as SYNTAX score; however, patients with HIV were more likely to have lesions in the proximal segment of the respective coronary artery. While both groups mostly displayed none/mild calcified lesions, HIV+ patients had longer and fewer stenotic lesions. Clinical outcomes at one year were similar. CONCLUSIONS While HIV+ patients were more likely to present with STEMI, detailed coronary angiographic analysis revealed less complex lesions and favourable anatomy. This paradox may suggest alterations in genesis and progression of atherosclerosis in this clinical setting.
Collapse
|
11
|
Mennuni MG, Stefanini GG, Pagnotta PA, Pllaha E, Araco M, Meelu OA, Turati F, Reimers B, Sardella G, Presbitero P. Clinical outcomes of bioresorbable versus durable polymer-coated everolimus-eluting stents in real-world complex patients. EUROINTERVENTION 2017; 12:1978-1986. [PMID: 27993752 DOI: 10.4244/eij-d-16-00276] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
AIMS The aim of this study was to evaluate the safety and efficacy profile of new-generation, SYNERGY everolimus-eluting stents (S-EES) as compared to XIENCE everolimus-eluting stents (X-EES) with a durable polymer coating in "complex patients". METHODS AND RESULTS We included 2,001 consecutive patients treated with S-EES (n=400) or X-EES (n=1,601) at two Italian centres between May 2013 and May 2015. We used propensity score matching to obtain two cohorts of patients with similar baseline risk profiles. Patients were stratified according to baseline complexity based on the EVOLVE II trial exclusion criteria. The primary outcome was major adverse cardiac events (MACE), defined as the composite of all-cause death, myocardial infarction (MI), and target lesion revascularisation (TLR), at one year. Among 391 matched pairs of patients treated with S-EES or X-EES, we identified 253 (63%) as complex. At one-year follow-up, among "complex" patients, MACE rates did not differ between the S-EES and X-EES groups (9.9% vs. 9.5%, p=0.830, HR 1.04, CI: 0.72-1.48). Similarly, death, MI, and TLR, stratified for complexity, were comparable between S-EES and X-EES treated patients at one year. Of note, no definite ST was observed in either the S-EES or the X-EES cohort. CONCLUSIONS New-generation S-EES with a bioresorbable polymer coating appear to be safe and effective irrespective of patient complexity as compared to X-EES.
Collapse
Affiliation(s)
- Marco G Mennuni
- Cardio Center, Humanitas Research Hospital, Rozzano-Milan, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Meelu OA, Mennuni MG, Theodoropoulos K, Sartori S, Baber U, Mehran R, Sharma SK, Kini AS, Dangas GD. Classification and patterns of bifurcation in-stent restenosis (BISR) in the second generation drug eluting stent era. Hellenic J Cardiol 2017; 58:167-168. [PMID: 28545912 DOI: 10.1016/j.hjc.2016.08.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2016] [Accepted: 08/22/2016] [Indexed: 11/19/2022] Open
|
13
|
Spaulding C, Mennuni MG. Surgery After DES Implantation: To Operate or Not to Operate: Is It Still a Question? J Am Coll Cardiol 2016; 68:2633-2636. [PMID: 27978947 DOI: 10.1016/j.jacc.2016.09.960] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/31/2016] [Accepted: 09/06/2016] [Indexed: 10/20/2022]
Affiliation(s)
- Christian Spaulding
- Cardiology Department, European Hospital Georges Pompidou, INSERM U 970 and Sudden Death Expert Center, Paris Descartes University, Paris, France.
| | - Marco G Mennuni
- Cardiology Department, European Hospital Georges Pompidou, INSERM U 970 and Sudden Death Expert Center, Paris Descartes University, Paris, France; Cardiology Department, Humanitas Research Hospital, Milan, Italy
| |
Collapse
|
14
|
Mennuni MG, Presbitero P. In-Stent Restenosis in New Generation DES Era. Interv Cardiol 2016. [DOI: 10.1002/9781118983652.ch21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Affiliation(s)
- Marco G. Mennuni
- Department of Cardiology; Humanitas Research Hospital; Rozzano Milan Italy
| | | |
Collapse
|
15
|
Meelu OA, Baber U, Theodoropoulos K, Mennuni MG, Kini AS, Sharma SK. Acute cholecystitis and myocardial infarction: a case study with coronary involvement. Clin Case Rep 2016; 4:793-6. [PMID: 27525087 PMCID: PMC4974431 DOI: 10.1002/ccr3.621] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2015] [Revised: 03/19/2016] [Accepted: 06/09/2016] [Indexed: 11/28/2022] Open
Abstract
Possible links between inflammatory stimuli and atherothrombotic disease in the context of gallbladder pathology are not well understood. Our case demonstrates that clinical suspicion of cardiac disease after a diagnosis of acute cholecystitis should remain high in light of the dire consequences of a missed diagnosis.
Collapse
Affiliation(s)
- Omar A Meelu
- Mount Sinai Heart Mount Sinai Medical Center New York New York USA
| | - Usman Baber
- Mount Sinai Heart Mount Sinai Medical Center New York New York USA
| | | | - Marco G Mennuni
- Mount Sinai Heart Mount Sinai Medical Center New York New York USA
| | | | - Samin K Sharma
- Mount Sinai Heart Mount Sinai Medical Center New York New York USA
| |
Collapse
|
16
|
Affiliation(s)
- Antoine Lafont
- Cardiology Department, Hôpital Georges Pompidou, Assistance Publique Hôpitaux de Paris, University Paris-Descartes, France.
| | - Marco G Mennuni
- Cardiology Department, Hôpital Georges Pompidou, Assistance Publique Hôpitaux de Paris, University Paris-Descartes, France
| |
Collapse
|
17
|
Theodoropoulos K, Mennuni MG, Dangas GD, Meelu OA, Bansilal S, Baber U, Sartori S, Kovacic JC, Moreno PR, Sharma SK, Mehran R, Kini AS. Resistant in-stent restenosis in the drug eluting stent era. Catheter Cardiovasc Interv 2016; 88:777-785. [DOI: 10.1002/ccd.26559] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/04/2015] [Revised: 03/01/2016] [Accepted: 03/21/2016] [Indexed: 01/09/2023]
Affiliation(s)
- Kleanthis Theodoropoulos
- Interventional Cardiovascular Research and Clinical Trials, The Icahn School of Medicine at Mount Sinai; New York New York
| | - Marco G. Mennuni
- Interventional Cardiovascular Research and Clinical Trials, The Icahn School of Medicine at Mount Sinai; New York New York
- Division of Clinical and Interventional Cardiology; Humanitas Research Hospital; Rozzano Milan Italy
| | - George D. Dangas
- Interventional Cardiovascular Research and Clinical Trials, The Icahn School of Medicine at Mount Sinai; New York New York
| | - Omar A. Meelu
- Interventional Cardiovascular Research and Clinical Trials, The Icahn School of Medicine at Mount Sinai; New York New York
| | - Sameer Bansilal
- Interventional Cardiovascular Research and Clinical Trials, The Icahn School of Medicine at Mount Sinai; New York New York
| | - Usman Baber
- Interventional Cardiovascular Research and Clinical Trials, The Icahn School of Medicine at Mount Sinai; New York New York
| | - Samantha Sartori
- Interventional Cardiovascular Research and Clinical Trials, The Icahn School of Medicine at Mount Sinai; New York New York
| | - Jason C. Kovacic
- Interventional Cardiovascular Research and Clinical Trials, The Icahn School of Medicine at Mount Sinai; New York New York
| | - Pedro R. Moreno
- Interventional Cardiovascular Research and Clinical Trials, The Icahn School of Medicine at Mount Sinai; New York New York
| | - Samin K. Sharma
- Interventional Cardiovascular Research and Clinical Trials, The Icahn School of Medicine at Mount Sinai; New York New York
| | - Roxana Mehran
- Interventional Cardiovascular Research and Clinical Trials, The Icahn School of Medicine at Mount Sinai; New York New York
| | - Annapoorna S. Kini
- Interventional Cardiovascular Research and Clinical Trials, The Icahn School of Medicine at Mount Sinai; New York New York
| |
Collapse
|
18
|
Garg A, Mennuni MG, Theodoropoulos K, Sharma A, Kostis J, Stefanini GG. TCT-463 Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting In Left Main Coronary Artery Disease: Long-Term Follow-Up Meta-Analysis Of 6156 Patients. J Am Coll Cardiol 2015. [DOI: 10.1016/j.jacc.2015.08.479] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
19
|
Theodoropoulos K, Mennuni MG, Garg A, Sharma A, Stefanini GG. TCT-464 Long-Term Mortality Of Percutaneous Coronary Intervention With Drug-Eluting Stents Compared To Bypass Surgery In Patients With Left Main Disease Stratified By The SYNTAX Score: Comprehensive Systematic Review And Meta-Analysis Of 3372 Patients. J Am Coll Cardiol 2015. [DOI: 10.1016/j.jacc.2015.08.480] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
20
|
Mennuni MG, Dangas GD, Mehran R, Ben-Gal Y, Xu K, Généreux P, Brener SJ, Feit F, Lincoff AM, Ohman EM, Hamon M, Stone GW. Coronary Artery Bypass Surgery Compared With Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Treatment in Patients With Acute Coronary Syndrome: Analysis From the ACUITY Trial. J Invasive Cardiol 2015; 27:468-473. [PMID: 26121708] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
BACKGROUND The optimal revascularization strategy in patients with acute coronary syndrome (ACS) and proximal left anterior descending (pLAD) coronary artery lesions is not well defined. The aim of this study was to compare the outcomes of ACS patients with pLAD culprit lesions receiving percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG). METHODS The ACUITY trial was a multicenter, prospective trial of patients with ACS treated with an early invasive strategy. Major adverse cardiac event (MACE; defined as death, myocardial infarction [MI], and repeat revascularization) and stroke were compared at 30 days and 1 year between PCI and CABG in patients with significant stenosis of the pLAD undergoing revascularization. Postprocedural major bleeding was evaluated at 30 days. RESULTS Among patients with a significant pLAD stenosis (n = 842), a total of 562 (66.7%) underwent PCI and 280 (33.3%) underwent CABG. Baseline characteristics, including age, sex, diabetes, and TIMI risk score, were well matched between groups; however, patients undergoing PCI were more likely to have had previous CABG (21.9% vs 6.4%; P<.001). Death, MI, MACE, and stroke rates did not differ between groups at 1 year. PCI patients had lower bleeding rates (8.1% vs 52.4%; P<.001) and blood product transfusion at 30 days (4.5% vs 41.3%; P<.001), but higher rates of unplanned revascularization at 1 year (12.7% vs 5.2%; P<.01). These results were consistent in patients with single vs multivessel disease and in diabetics vs non-diabetics. CONCLUSIONS Among ACS patients with pLAD culprit lesions, an initial revascularization strategy of PCI compared with CABG yields similar 1-year death, MI, and MACE rates, although unplanned revascularization is more common after PCI.
Collapse
Affiliation(s)
- Marco G Mennuni
- Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1030, New York, NY 10029 USA.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Panico C, Mennuni MG, Rossi ML, Zavalloni D, Gasparini GL, Soldi M, Stefanini GG, Condorelli G, Presbitero P, Pagnotta P. TCT-675 New-onset intraventricular conduction delays with the Edwards Sapien 3 transcatheter aortic valve. J Am Coll Cardiol 2015. [DOI: 10.1016/j.jacc.2015.08.694] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
22
|
Mennuni MG, Pagnotta PA, Stefanini GG. Coronary Stents: The Impact of Technological Advances on Clinical Outcomes. Ann Biomed Eng 2015; 44:488-96. [DOI: 10.1007/s10439-015-1399-z] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2015] [Accepted: 07/17/2015] [Indexed: 12/29/2022]
|
23
|
Pagnotta P, Mennuni MG, Ferrante G, Ornaghi D, Bragato R, Cappai A, Presbitero P. A Hybrid Double Access for Transcatheter Mitral Valve-In-Valve Implantation. Ann Thorac Surg 2015; 99:e149-50. [PMID: 26046908 DOI: 10.1016/j.athoracsur.2015.02.101] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/12/2015] [Revised: 02/12/2015] [Accepted: 02/17/2015] [Indexed: 11/25/2022]
Abstract
We present a case of hybrid mitral valve-in valve implantation. The planned transapical approach failed due to the inability to cross the degenerated stenotic mitral bioprosthesis. An alternative strategy was performed: first, an anterograde crossing of mitral stenosis, and then, a guidewire externalization through the apex by using a snare. To our knowledge, this is the first described case of double approach mitral valve-in valve implantation.
Collapse
Affiliation(s)
- Paolo Pagnotta
- Department of Interventional Cardiology, Humanitas Research Hospital, Rozzano, Milan, Italy
| | - Marco G Mennuni
- Department of Interventional Cardiology, Humanitas Research Hospital, Rozzano, Milan, Italy.
| | - Giuseppe Ferrante
- Department of Interventional Cardiology, Humanitas Research Hospital, Rozzano, Milan, Italy
| | - Diego Ornaghi
- Department of Cardiothoracic Surgery, Humanitas Research Hospital, Rozzano, Milan, Italy
| | - Renato Bragato
- Echocardiography Laboratory, Humanitas Research Hospital, Rozzano, Milan, Italy
| | - Antioco Cappai
- Department of Cardiothoracic Surgery, Humanitas Research Hospital, Rozzano, Milan, Italy
| | - Patrizia Presbitero
- Department of Interventional Cardiology, Humanitas Research Hospital, Rozzano, Milan, Italy
| |
Collapse
|
24
|
Meelu OA, Tomey MI, Sartori S, Kherada N, Mennuni MG, Theodoropoulos KN, Sayeneni S, Baber U, Pyo RT, Kovacic JC, Moreno P, Krishnan P, Mehran R, Dangas GD, Kini AS, Sharma SK. Comparison of provisional 1-stent and 2-stent strategies in diabetic patients with true bifurcation lesions: the EES bifurcation study. J Invasive Cardiol 2014; 26:619-623. [PMID: 25480989] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
BACKGROUND Percutaneous coronary intervention (PCI) of true bifurcation lesions (Medina classification 1, 1, 1; 1, 0, 1; or 0, 1, 1) is challenging and may involve either a 1-stent strategy with provisional side branch stenting, or a 2-stent strategy. Diabetes mellitus is associated with greater atherosclerotic burden and higher incidence of bifurcation lesions, and unfavorable outcomes after PCI. It is unknown whether use of newer everolimus-eluting stent (EES) implantation impacts relative outcomes of 1-stent and 2-stent strategies in patients with diabetes. METHODS We performed a retrospective analysis of consecutive patients with diabetes mellitus and complex true bifurcation lesions (side branch diameter >2.0 mm) who underwent PCI with EES between February 2010 and December 2011. We grouped subjects based on initial treatment to a 1-stent (n = 81) or 2-stent (n = 54) strategy, and compared baseline characteristics, quantitative coronary angiography, and 1-year major adverse cardiovascular event (MACE) rates, defined as death, myocardial infarction, target lesion revascularization (TLR), or target vessel revascularization (TVR). RESULTS Baseline characteristics were well matched. A 2-stent strategy was associated with larger side-branch reference vessel diameter at baseline and post PCI. In-hospital events included 1 periprocedural myocardial infarction in each group and no deaths. At 1 year, there was no significant difference between 1-stent and 2-stent strategies in TVR rates (6.2% vs 3.7%; P=.53), TLR (both 3.7%; P>.99), or MACE (7.4% vs 3.7%; P=.37). CONCLUSION In this series of diabetic patients undergoing complex bifurcation PCI using EES implantation, there was no difference between 1-stent and 2-stent strategies with respect to ischemic events at 1 year.
Collapse
Affiliation(s)
- Omar A Meelu
- Mount Sinai School of Medicine, New York, New York.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Mennuni MG, Pagnotta P, Zavalloni D, Rossi ML, Soldi M, Gasparini G, Ferrante G, Presbitero P. TCT-781 Impact of Smaller and Expandable Sheath During TAVR: Results From a Single-Center Registry. J Am Coll Cardiol 2014. [DOI: 10.1016/j.jacc.2014.07.853] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
26
|
Theodoropoulos K, Yu J, Mennuni MG, Sartori S, Meelu OA, Mastoris I, Baber U, Pyo RT, Kovacic J, Krishnan P, Moreno PR, Dangas G, Mehran R, Sharma S, Kini A. TCT-111 Gender Differences In The Burden Of Coronary Artery Disease In Patients With Human Immunodeficiency Virus Infection Undergoing Percutaneous Coronary Intervention. J Am Coll Cardiol 2014. [DOI: 10.1016/j.jacc.2014.07.140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
27
|
Christodoulidis G, Mennuni MG, Sartori S, baber U, Dangas G, Sharma S, Kini A, Tamburino C, Chieffo A, Colombo A, Presbitero P, Mehran R. TCT- 474 Triple vs. Dual Antithrombotic Therapy In Patients With Atrial Fibrillation And Acute Coronary Syndromes: The AVIATOR Registry. J Am Coll Cardiol 2014. [DOI: 10.1016/j.jacc.2014.07.528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
28
|
Bhasin A, Christodoulidis G, Mennuni MG, Sartori S, Baber U, Dangas G, Sharma S, Kini A, Tamburino C, Chieffo A, Colombo A, Presbitero P, Mehran R. TCT-477 Major Adverse Cardiovascular Events And Bleeding Risk Analysis In Elderly Afibrillation Patients Undergoing Percutaneous Coronary Intervention: The AVIATOR Registry. J Am Coll Cardiol 2014. [DOI: 10.1016/j.jacc.2014.07.531] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
29
|
Kherada NI, Sartori S, Tomey MI, Mennuni MG, Meelu OA, Roy S, Mohanty BD, Baber U, Pyo R, Kovacic JC, Sweeny J, Moreno P, Krishnan P, Dangas GD, Mehran R, Sharma SK, Kini AS. Dedicated two-stent technique in complex bifurcation percutaneous coronary intervention with use of everolimus-eluting stents: the EES-bifurcation study. Int J Cardiol 2014; 174:13-7. [PMID: 24731975 DOI: 10.1016/j.ijcard.2014.03.029] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/13/2013] [Accepted: 03/09/2014] [Indexed: 11/25/2022]
Abstract
OBJECTIVES To compare the outcomes of initial one-stent (1S) versus dedicated two-stent (2S) strategies in complex bifurcation percutaneous coronary intervention (PCI) using everolimus-eluting stents (EES). BACKGROUND PCI of true bifurcation lesions is technically challenging and historically associated with reduced procedural success and increased restenosis. Prior studies comparing initial one-stent (1S) versus dedicated two-stent (2S) strategies using first-generation drug-eluting stents have shown no reduction in ischemic events and more complications with a 2S strategy. METHODS We performed a retrospective study of 319 consecutive patients undergoing PCI at a single referral center with EES for true bifurcation lesions, defined by involvement of both the main vessel (MV) and side branch (SB). Baseline, procedural characteristics, quantitative coronary angiography and clinical outcomes in-hospital and at one year were compared for patients undergoing 1S (n=175) and 2S (n=144) strategies. RESULTS Baseline characteristics were well-matched. 2S strategy was associated with greater SB acute gain (0.65±0.41 mm vs. 1.11±0.47 mm, p<0.0001). In-hospital serious adverse events were similar (9% with 2S vs. 8% with 1S, p=0.58). At one year, patients treated by 2S strategy had non-significantly lower rates of target vessel revascularization (5.8% vs. 7.4%, p=0.31), myocardial infarction (7.8% vs. 12.2%, p=0.31) and major adverse cardiovascular events (16.6% vs. 21.8%, p=0.21). CONCLUSION In this study of patients undergoing PCI for true coronary bifurcation lesions using EES, 2S strategy was associated with superior SB angiographic outcomes without excess complications or ischemic events at one year.
Collapse
Affiliation(s)
- Nisharahmed I Kherada
- The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Samantha Sartori
- The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Matthew I Tomey
- The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Marco G Mennuni
- The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Omar A Meelu
- The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Swathi Roy
- The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Bibhu D Mohanty
- The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Usman Baber
- The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Robert Pyo
- The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Jason C Kovacic
- The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Joseph Sweeny
- The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Pedro Moreno
- The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Prakash Krishnan
- The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - George D Dangas
- The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Roxana Mehran
- The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, NY, United States.
| | - Samin K Sharma
- The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Annapoorna S Kini
- The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, NY, United States
| |
Collapse
|
30
|
Zavalloni D, Soldi M, Ferrante G, Mennuni MG, Gasparini GL, Pagnotta P, Rossi ML, Presbitero P. TCT-461 Isolated Left-Anterior-Descending Artery In-stent Restenosis: Comparison Between Treatment With PCI-DES And CABG With Left-Internal-Mammary Artery. J Am Coll Cardiol 2013. [DOI: 10.1016/j.jacc.2013.08.1204] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
31
|
Kherada NI, Mennuni MG, Meelu OA, Sartori S, Baber U, Sayeneni S, Roy S, Walker L, Mohanty BD, Tomey M, Looser P, Moreno PR, Krishnan P, Kovacic J, Pyo RT, Sweeny J, Dangas G, Mehran R, Sharma S, Kini A. TCT-400 Everolimus-Eluting Stent and Dedicated 2-Stent Strategy in Complex 'True' Bifurcation Lesion with Major Side Branch Involvement. J Am Coll Cardiol 2013. [DOI: 10.1016/j.jacc.2013.08.1140] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
32
|
Kherada NI, Mennuni MG, Meelu OA, Sartori S, Looser P, Baber U, Sayeneni S, Roy S, Walker L, Mohanty BD, Tomey M, Moreno PR, Krishnan P, Kovacic J, Pyo RT, Sweeny J, Dangas G, Mehran R, Sharma S, Kini A. TCT-414 Dedicated 2-stent versus 1-Stent Strategy in Diabetic Patients with Complex 'True' Bifurcation Lesion PCI using Everolimus-Eluting Stent. J Am Coll Cardiol 2013. [DOI: 10.1016/j.jacc.2013.08.1154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
33
|
Mennuni MG, Theodoropoulos K, Kherada NI, Aquino M, Baber U, Sartori S, Sayeneni S, Narechania B, Moreno PR, Krishnan P, Kovacic J, Pyo RT, Sweeny J, Dangas G, Mehran R, Sharma S, Kini A. TCT-482 "Resistant" In-Stent Restenosis in the Drug-Eluting Stent Era: An Angiographic Description and Outcomes. J Am Coll Cardiol 2013. [DOI: 10.1016/j.jacc.2013.08.1225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
34
|
Theodoropoulos K, Mennuni MG, Meelu OA, Sartori S, Aquino M, Moreno PR, Krishnan P, Kovacic J, Baber U, Dangas G, Mehran R, Sharma S, Kini A. TCT-479 Impact of Angiographic Patterns (Focal vs. Diffuse) of Resistant In-stent Restenosis on Clinical Outcomes. J Am Coll Cardiol 2013. [DOI: 10.1016/j.jacc.2013.08.1222] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
35
|
Mennuni MG, Theodoropoulos K, Mehran R, Bernelli C, Colombo A, Moreno PR, Krishnan P, Kovacic J, Baber U, Halperin JL, Kherada NI, Sartori S, Sayeneni S, Walker L, Roy S, Khalili L, Hasan C, Pyo RT, Sweeny J, Dangas G, Sharma S, Kini A. TCT-163 Do Patients with Paroxysmal Atrial Fibrillation in Sinus Rhythm during PCI Require Triple Therapy? Results from a Multicenter Center Study. J Am Coll Cardiol 2013. [DOI: 10.1016/j.jacc.2013.08.896] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
36
|
Mennuni MG, Theodoropoulos K, Meelu OA, Moreno PR, Krishnan P, Kovacic J, Baber U, Aquino M, Sartori S, Pyo RT, Sweeny J, Dangas G, Mehran R, Sharma S, Kini A. TCT-481 Treatment of "resistant" in-stent restenosis in the drug-eluting era: comparison of repeat stent versus balloon only strategy. J Am Coll Cardiol 2013. [DOI: 10.1016/j.jacc.2013.08.1224] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
37
|
Corrada E, Mennuni MG, Grieco N, Sesana G, Beretta G, Presbitero P. Neurological recovery after out-of-hospital cardiac arrest: hospital admission predictors and one-year survival in an urban cardiac network experience. Minerva Cardioangiol 2013; 61:451-460. [PMID: 23846011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
AIM The aim of the study was to detect early predictors of neurological recovery and evaluate one year survival related to neurological status at discharge in patients (pts) admitted after out of hospital cardiac arrest (OHCA). METHODS Sixty-three consecutive pts with OHCA from any cardiac cause, admitted to our cardiac intensive care unit, were classified according to survival and cerebral performance category (CPC) scale from 1 to 4 at hospital discharge. Pre-hospital and emergency room (ER) variables were analyzed to identify early predictors of neurological recovery as defined CPC=1-2. RESULTS Overall in-hospital survival was 60%. Sixty-eight and 32% of survivors were classified as CPC 1-2 and CPC 3-4 respectively. During one year follow-up 96% of patients classified as CPC 1-2 survived and 100% of CPC 3-4 died. Emergency crew witnessing, performance of cardio pulmonary resuscitation (CPR) by witnesses, the call for chest pain, no history of heart disease and a Glasgow coma scale (GCS) of ≥9 on arrival to the ER, were more frequent in patients classified as CPC 1-2 and times from "OHCA to return of spontaneous circulation (ROSC)", from "emergency medical system (EMS) arrival to ROSC" and "first DC shock to ROSC" were also significantly shorter in these patients. The time of first DC shock to ROSC in pts who presented with rhythm in ventricular fibrillation and the time from OHCA to ROSC in pts with witnessed OHCA were an independent predictors of neurological recovery. CONCLUSION Forty-one percent of pts admitted to our tertiary centre after OHCA were discharged with CPC 1-2 and at one year follow-up 96% of these were alive, while all pts classified as CPC 3-4 died. Easily documented information such as the time from OHCA to ROSC and the time of first shock to ROSC are early independent predictors of neurological recovery.
Collapse
Affiliation(s)
- E Corrada
- Cardiovascular Department, Humanitas Clinical and Research Center, Rozzano, Milan, Italy -
| | | | | | | | | | | |
Collapse
|